Symptom severity, interference with daily functioning were improved ...

Incremental dose to neurogenic niches correlated with reduced overall survival: SVZ HR 1.306/Gy and hippocampus HR 1.222/Gy, indicating independent adverse prognostic impact.

In a Phase III randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better ...

While tremendous relief comes from successfully battling cancer, survivors can also experience cognitive impairments caused by the disease and its treatment. Up to 70% of survivors experience trouble ...

CLEVELAND, Ohio — The Ohio State University’s James Cancer Hospital has treated the world’s first brain cancer patient to receive a new radiation technology that attacks tumors from within, the ...

Brain metastases are far from a niche concern; with 100,000 to 200,000 cases diagnosed annually in the US, the scale of the ...

Glioblastoma is the diagnosis that neuro-oncologists dread and patients fear, a fast-growing brain cancer that resists surgery, radiation, and chemotherapy and almost always returns. For decades, the ...

Edward (Ed) Waldner had no idea why he didn't feel well, but he knew he didn't feel like himself. At 55 years of age, he felt ...

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...